18.03.2013F2G Ltd. Appoints Ian Nicholson as Chief Executive Officer Manchester


F2G Ltd, the UK-based antifungal drug discovery and development company, today announced the appointment of Ian Nicholson to the position of CEO and to the Board of Directors .

Press Release

12.12.2012Algeta’s partner Bayer submits Radium-223 Dichloride for EU Marketing Authorisation

Submission to trigger €50 million milestone payment to Algeta

Press Release

05.09.2012F2G Ltd Completes $30 Million Financing Round to Fund Pre-clinical and Clinical Development of Novel Anti-fungal Compounds

Antifungal drug discovery and development company announces the completion of a $30 million equity financing round

Press Release